Myocardial Dysfunction in Long-Term Breast Cancer Survivors Treated at Ages 40–50 Years

Abstract

Impaired GLS and increased NT-proBNP levels are present in a substantial proportion of young BC survivors treated with anthracyclines. Whether this will lead to future cardiac disease needs to be evaluated by longitudinal assessment.